Active, Not Recruiting
Study of Nivolumab and Relatlimab in Advanced Mismatch Repair Deficient Cancers Resistant to Prior PD-(L)1 Inhibitor
NCT03607890
- Conditions
- Genomic Instability, MSI-H Tumors, Microsatellite Instability, +4 more
- Locations
-
- Cedars Sinai Medical Center Los Angeles, California, United States
- Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States